Tuberculosis in the 21th century: Current status of diagnostic methods

References

• Galagan JE. Genomic insights into tuberculosis. Nat Rev Genet. 2014;15:307–320. doi:10.1038/nrg3664.
   Web of Science ®Google Scholar
• Warner DF, Koch A, Mizrahi V. Diversity and disease pathogenesis in Mycobacterium tuberculosis. Trends Microbiol. 2015;23(1):14–21. doi:10.1016/j.tim.2014.10.005.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Tuberculosis Report 2018. ISBN 978-92-4-156564-6
   Google Scholar
• Siddiqi S, Ahmed A, Asif S, et al. Direct drug susceptibility testing of mycobacterium tuberculosis for rapid detection of multidrug resistance using the Bactec MGIT 960 System: A Multicenter Study. J Clin Microbiol. 2012;50(2):435–440. doi:10.1128/JCM.05188-11.
   PubMed Web of Science ®Google Scholar
• McNerney R, Cunningham J, Hepple P, Zumla A. New tuberculosis diagnostics and rollout. Int J Infect Dis. 2015;32:81–86. doi:10.1016/j.ijid.2015.01.012.
   PubMed Web of Science ®Google Scholar
• Fogel N. Tuberculosis: A disease without boundaries. Tuberculosis. 2015;95(5):527–531. doi:10.1016/j.tube.2015.05.017.
   PubMed Web of Science ®Google Scholar
• Comas I, Coscolla M, Luo T, et al. Out-of-Africa migration and Neolithic co-expansion of Mycobacterium tuberculosis with modern humans. Nat Genet. 2013;45(10):1176–1182. doi:10.1038/ng.2744.
   PubMed Web of Science ®Google Scholar
• George R, Cavalcante R, Carvalho Jr C, Marques E, Waugh JB, Unlap MT. Use of siRNA molecular beacons to detect and attenuate mycobacterial infection in macrophages. World J Exp Med. 2015;5(3):164–181. doi:10.5493/wjem.v5.i3.164.
   PubMedGoogle Scholar
• Abbas K, Fausto N, Aster J. R Infectious Diseases. Robbins and Cotran pathologic basis of disease. Pennsylvania: Elsevier; 2010.
   Google Scholar
• Zumla A, Nahid P, Cole ST. Advances in the development of new tuberculosis drugs and treatment regimens. Nat Rev Drug Discov. 2013;12:388–404. doi:10.1038/nrd4001.
   PubMed Web of Science ®Google Scholar
• Gagneux S. Genetic diversity in mycobacterium tuberculosis BT - Pathogenesis of Mycobacterium tuberculosis and its Interaction with the Host Organism. In: Pieters J, McKinney JD, eds. Berlin, Heidelberg: Springer Berlin Heidelberg; 2013:1–25. doi:10.1007/82_2013_329.
   Google Scholar
• Eva B, Philip S, Nadine H, Torsten S, ST P, Roland B. A glimpse into the past and predictions for the future: the molecular evolution of the tuberculosis agent. Mol Microbiol. 2014;93(5):835–852. doi:10.1111/mmi.12720.
   PubMed Web of Science ®Google Scholar
• Pérez-Lago L, Comas I, Navarro Y, et al. Whole genome sequencing analysis of intrapatient microevolution in mycobacterium tuberculosis: Potential impact on the inference of tuberculosis transmission. J Infect Dis. 2014;209(1):98–108.
   PubMed Web of Science ®Google Scholar
• Olivier I, Loots D. An overview of tuberculosis treatments and diagnostics. What role could metabolomics play? J Cell Tissue Res. 2011;11:2655–2671.
   Google Scholar
• WHO. Diagnostics for tuberculosis, global demand and market potential. Geneva, Switzerland: WHO; 2006:33–49.
   Google Scholar
• Getahun H, Harrington M, O’Brien R, Nunn P. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet. 2007;369(9578):2042–2049. doi:10.1016/S0140-6736(07)60284-0.
   PubMed Web of Science ®Google Scholar
• Rasoahanitralisoa R, Rakotosamimanana N, Stucki D, Sola C, Gagneux S, Rasolofo Razanamparany V. Evaluation of spoligotyping, SNPs and customised MIRU-VNTR combination for genotyping Mycobacterium tuberculosis clinical isolates in Madagascar. PLoS One. 2017;12(10):e0186088. doi:10.1371/journal.pone.0186088.
   PubMed Web of Science ®Google Scholar
• Gazi MA, Islam MR, Kibria MG, Mahmud Z. General and advanced diagnostic tools to detect Mycobacterium tuberculosis and their drug susceptibility: A review. Eur J Clin Microbiol Infect Dis. 2015;34(5):851–861. doi:10.1007/s10096-014-2306-5.
   PubMed Web of Science ®Google Scholar
• Gori A, Bandera A, Marchetti G, et al. Spoligotyping Mycobacterium tuberculosis. Emerg Infect Dis. 2005;11(8):1242–1248.
   PubMed Web of Science ®Google Scholar
• Drobniewski F, Nikolayevskyy V, Maxeiner H, et al. Rapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementation. BMC Med. 2013;11(1):190. doi:10.1186/1741-7015-11-190.
   PubMedGoogle Scholar
• Nathavitharana RR, Cudahy PGT, Schumacher SG, Steingart KR, Pai M, Denkinger CM. Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2017;49(1): pii:1601075. http://erj.ersjournals.com/content/49/1/1601075.abstract.
   Web of Science ®Google Scholar
• Wilson ML. Rapid diagnosis of Mycobacterium tuberculosis Infection and Drug Susceptibility Testing. Arch Pathol Lab Med. 2013;137(6):812–819. doi:10.5858/arpa.2011-0578-RA.
   PubMed Web of Science ®Google Scholar
• Singh BK, Sharma SK, Sharma R, et al. Diagnostic utility of a line probe assay for multidrug resistant-TB in smear-negative pulmonary tuberculosis. PLoS One. 2017;12(8):e0182988. doi:10.1371/journal.pone.0182988.
   PubMed Web of Science ®Google Scholar
• Gondil VS, Chhibber S. Exploring potential of phage therapy for tuberculosis using model organism. Biomed Biotechnol Res J. 2018;2(9):9–15. doi:10.4103/bbrj.bbrj.
   Google Scholar
• Rishi E, Rishi P, Therese KL, et al. Culture and Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) proven mycobacterium tuberculosis endophthalmitis: A case series. Ocul Immunol Inflamm. 2018;26(2):220–227. doi:10.1080/09273948.2016.1207786.
   PubMed Web of Science ®Google Scholar
• Bento J, Silva A, Rodrigues F, Duarte R. Diagnostic tools in tuberculosis. Acta Med Port. 2011;24(1):145–154.
   PubMed Web of Science ®Google Scholar
• Blakemore R, Story E, Helb D, et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol. 2010;48(7):2495–2501. doi:10.1128/JCM.00128-10.
   PubMed Web of Science ®Google Scholar
• Munir MK, Rehman S, Iqbal R, Saeed MS. Comparison of gene Xpert MTB/RIF assays with conventional standard proportion method for determination of drug susceptibility in multidrug resistant TB suspects. Annals of King Edward Medical University. 2018;24(1):86–92.
   Google Scholar
• Nhu NTQ, Heemskerk D, Thu DDA, et al. Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis. Carroll KC, ed. J Clin Microbiol. 2014;52(1):226–233. doi:10.1128/JCM.01834-13.
   PubMed Web of Science ®Google Scholar
• Chakravorty S, Simmons AM, Rowneki M, et al. The new Xpert MTB/RIF ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing. mBio 2017;8(4):e00812–e00817. doi:10.1128/mBio.00812-17.
   Google Scholar
• Kasa Tom S, Welch H, Kilalang C, et al. Evaluation of Xpert MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea. Paediatr Int Child Health. 2018;38(2):97–105. doi:10.1080/20469047.2017.1319898.
   PubMed Web of Science ®Google Scholar
• Lima TM de, Belotti NCU, Nardi SMT, Pedro H da SP. Teste rápido molecular GeneXpert MTB/RIF para diagnóstico da tuberculose. Rev Pan-Amazônica Saúde. 2017;8(2):65–76. doi:10.5123/S2176-62232017000200008.
   Google Scholar
• Nikam C, Jagannath M, Narayanan MM, et al. Rapid diagnosis of Mycobacterium tuberculosis with Truenat MTB: A Near-Care Approach. Neyrolles O, ed. PLoS One. 2013;8(1):e51121. doi:10.1371/journal.pone.0051121.
   PubMed Web of Science ®Google Scholar
• Nikam C, Kazi M, Nair C, et al. Evaluation of the Indian TrueNAT micro RT-PCR device with GeneXpert for case detection of pulmonary tuberculosis. Int J Mycobacteriology. 2014;3(3):205–210. doi:10.1016/j.ijmyco.2014.04.003.
   PubMedGoogle Scholar
• Baron EJ, Tenover FC, Gnanashanmugam D. Direct detection of mycobacterium tuberculosis in clinical specimens using nucleic acid amplification tests. Clin Microbiol Newsl. 2018;40(13):107–112. doi:10.1016/j.clinmicnews.2018.06.003.
   Google Scholar
• Augusto CJ, Carvalho W da S, Almeida IN de, et al. Comparative study of RFLP-IS6110 and MIRU-VNTR from Mycobacterium tuberculosis isolated in the state of Minas Gerais, Brazil. Brazilian J Microbiol. 2018;49(3):641–646. doi:10.1016/j.bjm.2017.04.015.
   PubMed Web of Science ®Google Scholar
• Khan AS, Ali S, Khan MT, et al. Comparison of GeneXpert MTB/RIF assay and LED-FM microscopy for the diagnosis of extra pulmonary tuberculosis in Khyber Pakhtunkhwa, Pakistan. Brazilian J Microbiol. 2018;49(4):909–913. doi:10.1016/j.bjm.2018.02.011.
   PubMed Web of Science ®Google Scholar
• Daum LT, Konstantynovska OS, Solodiankin OS, et al. Next-generation sequencing for characterizing drug resistant mycobacterium tuberculosis genes from clinical isolates in the Ukraine. J Clin Microbiol. 2018;56(6). doi:10.1128/JCM.00009-18.
   Web of Science ®Google Scholar
• Ma G, Pan J, Han J, Gao L, Zhang S, Li R. Identification of M. tuberculosis antigens in the sera of tuberculosis patients using biomimetic affinity chromatography in conjunction with ESI-CID-MS/MS. J Chromatogr B. 2017;1061–1062:452–458. doi:10.1016/j.jchromb.2017.07.052.
   PubMed Web of Science ®Google Scholar
• Shah J, Weltman H, Narciso P, et al. Dual color fluorescence in situ hybridization (FISH) assays for detecting Mycobacterium tuberculosis and Mycobacterium avium complexes and related pathogens in cultures. PLoS One. 2017;12(4):e0174989. doi:10.1371/journal.pone.0174989.
   PubMed Web of Science ®Google Scholar
• Neonakis IK, Spandidos DA, Petinaki E. Use of loop-mediated isothermal amplification of DNA for the rapid detection of Mycobacterium tuberculosis in clinical specimens. Eur J Clin Microbiol Infect Dis. 2011;30(8):937–942. doi:10.1007/s10096-011-1195-0.
   PubMed Web of Science ®Google Scholar
• Haas CT, Roe JK, Pollara G, Mehta M, Noursadeghi M. Diagnostic ‘omics’ for active tuberculosis. BMC Med. 2016;14(1):37. doi:10.1186/s12916-016-0583-9.
   PubMedGoogle Scholar
• Matkar S, Mukundan U. MALDI-TOF MS for rapid identification of Mycobacterium species in liquid culture media. J Bacteriol Mycol. 2018;6(2):105–107. doi:10.15406/jbmoa.2018.06.00185.
   Google Scholar
• Patel R. MALDI-TOF MS for the diagnosis of infectious diseases. Clin Chem. 2015;61(1): LP100–111. http://clinchem.aaccjnls.org/content/61/1/100.abstract.
   PubMed Web of Science ®Google Scholar
• Santos T, Capelo JL, Santos HM, et al. Use of MALDI-TOF mass spectrometry fingerprinting to characterize Enterococcus spp. and Escherichia coli isolates. J Proteomics. 2015;127:321–331. doi:10.1016/j.jprot.2015.02.017.
   PubMed Web of Science ®Google Scholar
• Sun H, Pan L, Jia H, et al. Label-free quantitative proteomics identifies novel plasma biomarkers for distinguishing pulmonary tuberculosis and latent infection. Front Microbiol. 2018;9:1267. doi:10.3389/fmicb.2018.01267.
   PubMed Web of Science ®Google Scholar
• Agranoff D, Fernandez-Reyes D, Papadopoulos MC, et al. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet. 2006;368(9540):1012–1021. doi:10.1016/S0140-6736(06)69342-2.
   PubMed Web of Science ®Google Scholar
• Wang C, Wei L-L, Shi L-Y, et al. Screening and identification of five serum proteins as novel potential biomarkers for cured pulmonary tuberculosis. Sci Rep. 2015;5:15615. doi:10.1038/srep15615.
   PubMed Web of Science ®Google Scholar
• Duncan C, Jamieson FB, Troudt J, et al. Whole transcriptomic and proteomic analyses of an isogenic M. tuberculosis clinical strain with a naturally occurring 15 Kb genomic deletion. PLoS One. 2017;12(6):e0179996. doi:10.1371/journal.pone.0179996.
   PubMed Web of Science ®Google Scholar
• Achkar JM, Cortes L, Croteau P, et al. Host protein biomarkers identify active tuberculosis in HIV uninfected and co-infected individuals. EBioMed. 2015;2(9):1160–1168. doi:10.1016/j.ebiom.2015.07.039.
   PubMed Web of Science ®Google Scholar
• Berry MPR, Graham CM, McNab FW, et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature. 2010;466:973. doi:10.1038/nature09247.
   PubMed Web of Science ®Google Scholar
• Mejias A, Suarez NM, Ramilo O. Detecting specific infections in children through host responses: A Paradigm Shift. Curr Opin Infect Dis. 2014;27(3):228–235. doi:10.1097/QCO.0000000000000065.
   PubMed Web of Science ®Google Scholar
• Weiner J, Parida SK, Maertzdorf J, et al. Biomarkers of inflammation, immunosuppression and stress are revealed by metabolomic profiling of tuberculosis patients. Wilkinson RJ, ed. PLoS One. 2012;7(7):e40221. doi:10.1371/journal.pone.0040221.
   PubMed Web of Science ®Google Scholar
• Lau SKP, Lee K-C, Curreem SOT, et al. Metabolomic profiling of plasma from patients with tuberculosis by use of untargeted mass spectrometry reveals novel biomarkers for diagnosis. Land GA, ed. J Clin Microbiol. 2015;53(12):3750–3759. doi:10.1128/JCM.01568-15.
   PubMed Web of Science ®Google Scholar
• Ahmad S, Mokaddas E. Current status and future trends in the diagnosis and treatment of drug-susceptible and multidrug-resistant tuberculosis. J Infect Public Health. 2014;7(2):75–91. doi:10.1016/j.jiph.2013.09.001.
   PubMed Web of Science ®Google Scholar
• Cudahy P, Shenoi S. Diagnostics for pulmonary tuberculosis. Postgrad Med J. 2016;92(1086):187–193. doi:10.1136/postgradmedj-2015-133278.
   PubMed Web of Science ®Google Scholar
• Hertting O, Shingadia D. Childhood TB: When to think of it and what to do when you do. J Infect. 2014;68:S151–S154. doi:10.1016/j.jinf.2013.09.025.
   PubMed Web of Science ®Google Scholar
• Heemskerk D, Caws M, Marais B, Farrar J. Tuberculosis in Adults and Children. London: Springer; 2015.
   Google Scholar